New York, USA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Market Overview: The global GLP-1 analogues market size was assessed at USD 46.70 billion in 2024. The market is expected to flourish and grow from ...
News Medical on MSN9d
Exenatide, a GLP-1 analog, by IV during cardiac surgery did not reduce organ injury or deathA large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...
Surprising research strongly suggests semaglutide can help fight substance use disorder. Why aren't we using it?
News Medical on MSN7d
Squid-inspired technology could replace needles for medications and vaccinesThe MiDe systems, inspired by squid propulsion, demonstrate effective needle-free drug delivery in the gastrointestinal tract ...
Readouts from Novo Nordisk and Viking Therapeutics at AASLD 2024 strengthen the argument for GLP-1 therapies as an emerging ...
(MENAFN- GlobeNewsWire - Nasdaq) The ability to act upon more than one disease and disorder has led to the GLP-1 analogues market has been getting a tremendous boost globally in recent times.
The ability to act upon more than one disease and disorder has led to the GLP-1 analogues market has been getting a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback